Rankings
▼
Calendar
FENC Q4 2020 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
FENC
Fennec Pharmaceuticals Inc.
$216M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$170,000
Gross Profit
$170,000
100.0% margin
Operating Income
-$3M
-1968.2% margin
Net Income
-$3M
-1904.7% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$577,000
Balance Sheet
Total Assets
$31M
Total Liabilities
$2M
Stockholders' Equity
$29M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$170,000
$0
—
Gross Profit
$170,000
$0
—
Operating Income
-$3M
-$4M
+10.0%
Net Income
-$3M
-$4M
+11.9%
← FY 2020
All Quarters
Q1 2021 →